Validation of Dry Heat Processes PDA TR-3
Validation of Dry Heat Processes PDA TR-3
Validation of Dry Heat Processes PDA TR-3
1
9/18/2019
Instructor Bio
Deborah Havlik
• DAHavlik Consulting, Greater Chicago Area
• Director, Pharmaceutical Microbiology, R&D,
Hospira, a Pfizer company
• Contract Micro Lab and Ethylene Oxide
Sterilization
• Medical Device Industry, Class III manufacturer
• PDA Task Force
• Convenor of ISO WG 14, Dry Heat; Microbiological
Methods
• AAMI: Radiation, Ethylene Oxide, Dry Heat,
Microbiological Methods, Aseptic Processing, BIs
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 3
Class Introductions
• Name
• Company
• Position/Title
• Student objectives/expectations
• Instructor’s learning objectives
2
9/18/2019
Announcements
• Attendance list
• Course/Instructor evaluations
• ACPE Form
• Disclosure
Course Schedule
3
9/18/2019
Course Outline
Section 1
Introduction
and Scope
4
9/18/2019
Introduction
Scope (1)
10
5
9/18/2019
Scope (2)
Use of biological indicators and endotoxin indicators
Process development
11
Scope
12
6
9/18/2019
Out of Scope
13
Section 2:
Glossary of Terms
14
7
9/18/2019
Glossary of Terms
15
Section 3:
16
8
9/18/2019
Sterilization
Dry Heat
OR
Processes
Depyrogenation
and sterilization
17
18
9
9/18/2019
Destruction of LPS
“Whereas many • 250 C for 30 minutes
sterilization
processes are
predictable, many
depyrogenation
procedures are Literature references
purely empirical.” • Lack of agreement in
temperature and times
Kevin Williams, Eli Lilly & • Many conditions affect
Co. depyrogenation
parameters
19
20
10
9/18/2019
21
22
11
9/18/2019
Validation
• Dry heat endotoxin reduction studies are always
conducted rather than microbial inactivation studies
• Inactivation rate of endotoxin is slower than the
inactivation rate of the biological indicator used (e.g.,
spores of Bacillus atropheus)
In Practice
• The reduction of endotoxin challenge by three or more
logs will result in a process that also achieves the
probability of non-sterility substantially less than 10-6
23
Greater than
Inactivation
of Endotoxin
= or = 3 log of
reduction
24
12
9/18/2019
Review Question #1
25
Review Question #2
26
13
9/18/2019
27
Glossary of Terms:
Endotoxin Indicator (EI)
An article challenge vial of endotoxin (or a
carrier spiked with endotoxin) designed for
use in depyrogenation studies.
28
14
9/18/2019
29
Endotoxin Indicators
A detailed guideline for preparing and recovering endotoxin challenges has been published.
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 30
30
15
9/18/2019
Two approaches
31
Washing/Rinsing
• Water for Bacterial
Endotoxin Testing (BET) Inoculation (spiking)
• Water for Injection (WFI) • High potency endotoxin
• Minimize intrinsic • Small volume
contamination resulting • Not less than 1,000
in false positives International Units (IU)
units
• One International Unit
(IU) = one Endotoxin
Unit (EU)
Note: the level of endotoxin with which to inoculate a carrier is somewhat controversial. Purified endotoxin, which is
used in depyrogenation studies, binds more thoroughly to the carrier surface and is more difficult to recover than
natural endotoxin
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 32
32
16
9/18/2019
Lipopolysaccharide
Ultrastructure
Of Gram –ve
Bacterial Cell
Wall
33
Glossary of Terms:
Water for Bacterial Endotoxin Test (BET)
34
17
9/18/2019
EI Fixation Methods
35
36
18
9/18/2019
37
Review Question #3
38
19
9/18/2019
Review Question #4
39
Recovery
40
20
9/18/2019
Glossary of Terms:
Bacterial Endotoxin Test (BET)
41
42
21
9/18/2019
Depyrogenation
Inactivation of
process will
endotoxin achieves May
Assume sufficiently inactivate
greater than or equal to
endogenous
3 logs of reduction
endotoxins that could
be present
43
Equation 3.2.4-1
IU0 = Average
ELR = Endotoxin recovered positive IUf = Recovered
Log Reduction control endotoxin spike concentration
concentration after exposure
(unprocessed)
44
22
9/18/2019
Average recovered
positive control Test indicators after Endotoxin log
endotoxin indicator heat treatment reduction
45
Glassware Depyrogenation
• Depyrogenation by washing, rinsing and the
sterilization process is as effective as dry heat
depyrogenation and is cost effective
• Manufacturing process for glass excludes the
potential for bioburden and endotoxin contamination
– Promptly packaged after production in a cleanroom
environment
– Subjected to shrink-wrap for delivery and storage
post cleaning
Note: Not all aspects of this TR are applicable to glassware or other containers that
are used to package products destined for terminal sterilization.
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 46
46
23
9/18/2019
Glassware Depyrogenation
47
48
24
9/18/2019
Assessment Considerations
Packaging to
Quality audit prevent
Handling and
of glass microbial and
shipping
manufacturer endotoxin
contamination
Storage
Storage conditions
conditions prior to and
prior to following
packaging shipping
49
Environmental
controls to
Inadvertent in- protect
transit damage glassware once
affecting packed and/or
Inspection of washed
shipping integrity of
containers upon shipping
receipt for water container
damage
50
25
9/18/2019
51
Review Question #5
52
26
9/18/2019
Review Question #6
53
Slow-acting
sterilizing
agent
Higher
temperatures
Longer
Image courtesy of spaulding-rogers.com exposure
times
54
27
9/18/2019
Glossary of Terms:
Sterilization Process and Heat
55
56
28
9/18/2019
Sterilization
Rate of Temperature
microbiological
destruction Uniformity of the heating medium
influenced by:
57
Sterilization:
Mechanisms of Inactivation (1)
• Typical dry heat temperatures are greater
than or equal to 160°C
– However processes at significantly lower
temperatures have been developed and
validated
• Dry heat inactivates microorganisms
primarily by oxidizing organic compounds
58
29
9/18/2019
Water
Temperature Time
content
59
60
30
9/18/2019
61
Glossary of Terms:
F-Value and z-value
F-Value (Lethality Factor):
z-value:
62
31
9/18/2019
63
64
32
9/18/2019
Glossary of Terms:
Routine Operational Process
65
Glossary of Terms:
Heat-Up Phase
66
33
9/18/2019
67
FH Values:
Equation 3.3.1.1-1
Theoretical FH values z-value = 20°C
can be calculated
using the following
parameters: Tref-value = 160°C
n
T i - T ref
FH t 10
z
i
i 1
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 68
68
34
9/18/2019
FH Values (2)
n
T i - T ref
FH t 10
z
i
i 1
FH • Equivalent lethality in minutes
Tref • Reference temperature equal to 160.0 C
z • Spore lethality z-value equal to 20.0 C
69
D-Value z-Value
70
35
9/18/2019
Example
71
Review Question #7
72
36
9/18/2019
Review Question #8
73
Review Question #9
74
37
9/18/2019
75
76
38
9/18/2019
77
78
39
9/18/2019
Biological Indicators:
Sterilization Process
• The sterilization process can be
evaluated in one of two ways
– The BI can be exposed to a partial
process and the kill rate is calculated
– The BI can be exposed to an overkill
process
• Perform a determination of the stability of the
population and resistance of the BI
• Base the actual population and resistance on the
desired lethality and the design approach (e.g., overkill or
product specific approach)
79
80
40
9/18/2019
81
82
41
9/18/2019
83
Section 4.0:
Equipment Design
84
42
9/18/2019
Equipment Design
• Validation of dry heat depyrogenation and
sterilization cycles is dependent upon
– Equipment
– Load to be processed
• Goal is to deliver effective processes that are
consistent and reproducible
• Design and construction of the equipment governed
by User Requirement Specifications (URS)
• Successful qualification
– Formal verification of proper design
– Installation and operational testing
• Ensures design criteria and specifications are met
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 85
85
Overview
Design
Equipment Qualification
User
FAT SAT Installation Operational Performance
Requirements
Physical (Micro)Biological
86
43
9/18/2019
Glossary of Terms:
Sterilization Cycle
A sequence of defined
operating parameters
(e.g., time and
temperature) and
conditions required to
render an item sterile.
87
88
44
9/18/2019
Installation
location Safety
Control strategy
requirements considerations
and conditions
Utility
requirements
89
Equipment Design:
Dry Heat Process
Predominant
method
Forced
Accomplished Convection
by transferring Focus of
heat to the tunnel and
load through oven design
several means Conduction
90
45
9/18/2019
Equipment Design:
Convection Heating
91
Equipment Design:
Dry Heat Process
Forced
Accomplished
Convection
by transferring
Molecular
heat to the
Interaction
load through
several means Conduction
“Free”
Electrons
92
46
9/18/2019
Equipment Design:
Conduction Heating
93
Note: A later section will discuss design and test parameters for HEPA
filters used in dry heat ovens and tunnels.
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 94
94
47
9/18/2019
URS:
Oven and Tunnel Considerations
95
Equipment Design:
HEPA or ULPA Filters (1) Image courtesy of techrite.com
96
48
9/18/2019
Equipment Design:
HEPA and ULPA Filters (2)
97
Equipment Design:
HEPA and ULPA Filters (3)
98
49
9/18/2019
Glossary of Terms
99
Equipment Design:
Batch Convection Oven
• Typically controlled and monitored
by a programmable temperature
control system
– Provide appropriate temperature ramp,
exposure and cool down
Image courtesy of despatch.com • Monitor air flow and pressure
differential provided by the oven fan
• Control door interlocks during the
process and until the processed
load is unloaded to prevent ingress
into the oven
100
50
9/18/2019
Equipment Design:
Interlock System on a Double Door Batch
Convection Oven
• Mechanism to prevent:
– Opening of either door out of sequence
– Or both doors at the same time
• Maintain pressure gradient in an
environmentally controlled area:
Unloading Loading
Chamber
Area Area
Highest
pressure
101
Equipment Design:
Batch Convection Oven
Measure
Filter air differential
intake and pressure
exhaust vents across filters
Conduct risk
assessment to
determine the
type of filter
needed
102
51
9/18/2019
Example of Batch
Figure 4.1.2-1:
Convection Oven Showing Airflow
103
Equipment Design:
Continuous Convection Tunnel (1)
• Conveyor system moves load through heated
tunnel
– Predetermined load
– Predetermined rate
• May include three zones: Image courtesy of www.enceko.pl
104
52
9/18/2019
Equipment Design:
Continuous Convection Tunnel (2)
105
Figure 4.1.3-1:
Continuous Convection Tunnel
106
53
9/18/2019
Equipment Design:
Continuous Convection Tunnel (3)
107
Equipment Design:
Cool Zone Decontamination Methods
108
54
9/18/2019
Equipment Design:
Continuous Tunnels
• Typically include data recorders to monitor the
process and print process reports
• Monitor physical parameters
– Conveyor speed
– Temperature of the pre-heat zone
– Heat zone and cool down zones
– Forced air fan alarms
– Zone pressure
• System alarm indicates deviation from process
specifications
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 109
109
110
55
9/18/2019
111
112
56
9/18/2019
Section 5.0:
Equipment Qualification
113
Equipment Qualification:
Process Equipment
114
57
9/18/2019
Glossary of Terms
Commissioning:
• A well planned, documented and managed engineering
approach to the start-up and transfer of facilities, systems and
equipment to the end-user that results in a safe and functional
environment that meets established design and user
requirement specifications.
• Commissioning precedes Qualification and includes three
phases:
2) Adjustment
1) Inspection and 3) Functional/
and Setting to
Testing, Regulation Run Testing
Work
115
Operational Qualification
116
58
9/18/2019
117
Equipment Qualification:
Additional Functionality Testing (2)
118
59
9/18/2019
119
120
60
9/18/2019
121
Equipment Qualification:
Final Check
• A series of processes to verify each system
component
– Interacts correctly
– In the programmed sequence of events is
repeatable
• Use the appropriate standards for calibration
tolerance and calibration frequency for
instruments used to:
– Monitor critical operational parameters
– Monitor critical quality attributes
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 122
122
61
9/18/2019
123
124
62
9/18/2019
Equipment Verification:
Room Differential Pressure
• Establish requirements for oven or tunnel
• Impacts unit air flow and temperature distribution
• Verify air pressure differentials in operational testing of
sterilizer
• Minimum pressure differential established is dependent
on the system design
• Verify air balance between sterilizer and outside
environment
125
126
63
9/18/2019
127
Uniformity of Heat
128
64
9/18/2019
129
130
65
9/18/2019
131
132
66
9/18/2019
133
134
67
9/18/2019
135
136
68
9/18/2019
Section 6:
Process
Development
137
Process Development
138
69
9/18/2019
Process Development
• Represent actual
manufacturing
conditions (e.g.,
spraying vials with water
to simulate vial washing)
• Document
Image courtesy of www.pharmaceutical-int.com development process
139
Process Development:
Process Design Approaches
140
70
9/18/2019
Process Development:
Overkill Design Approach
• Depyrogenation Process
– Demonstrate a minimum of a 3 log reduction of endotoxin
at the coolest location in the worst load
• Sterilization Process
• Biological indicators used to demonstrate lethality
− Known population
− Resistance
• Bacillus atrophaeus generally used
• Deliver a probability of a non-sterile unit (PNSU) that is
less than or equal to 10-6
Note: Consider the potential for thermal degradation of items when overkill used
Probability of a Non-Sterile Unit (PNSU): The number that expresses the
probability of occurrence of a non-sterile unit after exposure to a sterilization
process
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 141
141
PNSU Formula
FH = Lowest FH No = initial
D = D160C-value of the BI
calculated within load population of BI
D160C-value = 2 minutes
FH = 30 minutes N0 = 1 x 106
142
71
9/18/2019
Calculation of PNSU
143
Process Development:
Product-Specific Approach (1)
144
72
9/18/2019
Process Development:
Product-Specific Approach (2)
145
Process Development:
Defining Operating Parameters
146
73
9/18/2019
147
Process Development:
Operational Parameters (1)
Develop operational parameters that ensure
Sterilization: minimum PNSU of a least 10-6
Depyrogenation: minimum 3 log reduction in endotoxin
Achieve parameters within the loads or
components
Use as a starting point for process or process
development
Perform temperature studies to determine worst
case conditions in load
148
74
9/18/2019
149
150
75
9/18/2019
151
Process Development:
Batch Oven Process Development
152
76
9/18/2019
Batch Oven:
Developing Load Patterns (1)
• Determine ‘worst case’ load based on
– Load mass
– Configuration
– Other parameters
• Verify choice
• Develop process parameters to achieve required
conditions of time and temperature
• Ovens: industry experience demonstrates validation of
maximum load for a given load configuration is considered
sufficient to validate loads of less mass (i.e. minimum
loads)
153
Glossary of Terms:
Worst Case, Maximum, and Minimum Loads
154
77
9/18/2019
Batch Oven:
Developing Load Patterns (2)
155
Batch Oven:
Developing Load Patterns (3)
• Raise large items (not on cart) off of floor to
allow air circulation
• Trolley position within the oven must be
reproducible and included in load pattern
documentation
• Load orientation can affect item heat up
• Trays, racks, carts
• Should not generate particulates
• Must withstand heating process without
degradation
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 156
156
78
9/18/2019
Batch Oven:
Developing Load Patterns (4)
157
158
79
9/18/2019
159
Glossary of Terms:
Exposure Phase/Dwell Time
160
80
9/18/2019
161
162
81
9/18/2019
163
164
82
9/18/2019
165
Continuous Convection
Tunnel Process Development (1)
166
83
9/18/2019
Continuous Convection
Tunnel Process Development (2)
• Tunnels may operate at a fixed belt speed and the number of
containers varied according to the demand from the filling
machine
• A variable speed belt offers greater operating flexibility and is
more common in newer installations
• The period during which the containers remain within the hot
zone, also referred to as the “sterilization / depyrogenation
dwell time”, is set by conveyor belt speed
• Required dwell time in the tunnel hot zone can be empirically
derived by thermal analysis during empty and loaded chamber
studies
Dwell Time: The period that items are subjected to a given processing condition.
[Synonym: Residence Time]
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 167
167
Continuous Tunnels:
Developing Loading Patterns (1)
• The ‘worst case’ load determined on the basis of the
following
– Load mass
– Configuration
– Other parameters
168
84
9/18/2019
Continuous Tunnels:
Developing Loading Patterns (2)
169
Continuous Tunnels:
Developing Loading Patterns (3)
Example
170
85
9/18/2019
Continuous Tunnels:
Developing Loading Patterns (4)
• Establish relationship between
Drying/ heating/
Washing Speed cooling zone belt Filling speed
speed
171
Continuous Tunnels:
Developing Loading Patterns (5)
• Introduce loads into the heating zone in a manner
representative of actual manufacturing conditions
• Determine thermometric conditions when the load
enters and exits the hot zone
• The largest load mass/unit area may be validated
as representative of the range of items to be
qualified
• Selection of the worst-case challenge(s)
conducted using scientific rationale and/or
determined through heat penetration or challenge
studies
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 172
172
86
9/18/2019
Continuous Tunnels:
Developing Loading Patterns (6)
Dry Heat The ‘worst case’ load for each temperature
setting must be determined by calculating the
Tunnels throughput of items (expressed in mass/time)
173
Continuous Tunnels:
Developing Loading Patterns Summary (1)
Selection of a “worst case” load simplifies the
validation approach to tunnel depyrogenation by
running studies under conditions which produce a
“worst case” challenge seen in production for the
following three categories:
Mass Rate of
Belt
per unit mass
speed
area loading
174
87
9/18/2019
Continuous Tunnels:
Developing Loading Patterns Summary (2)
The steps can be summarized as follows:
175
Loaded Tunnel
Temperature Distribution Studies
• Assess the impact of
the load on the ability
of the hot zone to
maintain temperature
uniformity
• May be conducted
concurrently with heat
penetration studies
Image courtesy of www.bausch-stroebel.com
176
88
9/18/2019
177
178
89
9/18/2019
179
180
90
9/18/2019
181
Figure 6.4.3-1
Glass Vial Load Heat Penetration Profile:
Continuous Convection Oven
182
91
9/18/2019
Typical Qualification
Acceptance Criteria
Minimum and
maximum
FH-values
temperatures
achieved
Minimum dwell
Variation in the
time achieved
temperature
above a defined
between probes
temperature
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 183
183
FH-Values
184
92
9/18/2019
185
186
93
9/18/2019
187
188
94
9/18/2019
Section 7:
Performance
Qualification
Performance Qualification (PQ): Documented verification that a system
is capable of consistently performing or controlling the activities of the
processes it is required to perform or control, according to written and
pre-approved specifications, while operating in its specified operating
environment
189
Performance Qualification
• Performance Qualification
– Process of obtaining and documenting evidence that the
equipment, as installed, consistently operates in
accordance with predetermined criteria
Biological
Physical Qualification
Qualification
190
95
9/18/2019
Performance Qualification:
Physical Qualification (1)
• Ensures the depyrogenation/ sterilization
process as developed is reproducible
– Physical Qualification
– Endotoxin/endotoxin qualification
• Verifies temperature profiles within the oven or
tunnel
• Ensure items reach required temperature for
specified time
Physical Qualification: A component of performance qualification that
demonstrates that pre-determined physical requirements including
temperature distribution and heat penetration are achieved consistently
throughout the load.
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 191
191
Performance Qualification:
Physical Qualifications (2)
• Confirm reproducibility of temperature
profiles developed in process development
by performing temperature distribution and
heat penetration qualification with ‘worst’
case loads
• Place calibrated temperature probes in the
coolest locations established during
process development temperature
distribution and heat penetration studies
• Confirm during heat penetration
qualification that items exiting the tunnel to
the filling suite are cooled to a product-safe
temperature Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 192
192
96
9/18/2019
Performance Qualification:
Biological Qualification
• Demonstrates that the required endotoxin
inactivation or lethality is achieved
consistently throughout load
– Endotoxin
– Biological Indicators
• Place indicators in numerous locations in
the load, including the most difficult to
depyrogenate or sterilize locations
Biological Qualification: A component of performance qualification that
demonstrates, by use of biological indicators, that the required lethality is
achieved consistently throughout the load.
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 193
193
Biological Qualification:
Dry Heat Depyrogenation
Validation data demonstrates the process consistently
reduces endotoxin by three (3) logs
• Inoculate articles to be treated with a minimum of 1,000
International Units (IU) of endotoxin per article
• Inoculated articles tested for endotoxin to demonstrate at
least 3 log reduction from original concentration after
treatment in the dry heat depyrogenation process
− Limulus Amebocyte Lysate (LAL) test
− Bacterial Endotoxins Test (BET)
• Where depyrogenation has been demonstrated,
sterilization is assured due to the lower resistance of
microorganisms to dry heat (as compared to bacterial endotoxin).
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 194
194
97
9/18/2019
Biological Qualification:
Dry Heat Sterilization
Validation data demonstrates the process
consistently delivers a microbial survivor
probability for the challenge organism of not less
than 10-6
• Select number of BIs and processes for
performance qualification (PQ) to cover
range of conditions in load during routine
processing
• Placement of BIs based on data from
process development
• Place each heat penetration probe in the
load adjacent to a BI location
195
Performance Qualification:
Biological Indicator Testing (1)
• Follow manufacturer’s
directions for use
– Medium and conditions to
be used for the recovery of
microorganisms after
exposure to the sterilization
process
• Aseptic technique when
testing BIs
• Investigate positive BIs
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 196
196
98
9/18/2019
Performance Qualification:
Biological Indicator Testing (2)
If a Determine the spore population, confirm purity
suspension and identity of the BI
is used for
direct or Stock suspension should be predominantly
carrier spores in a non-nutritive liquid
inoculation,
consider the Determine the D-value (This is done on the
following item being sterilized if the BI is inoculated onto
the item)
points:
Preparation of the BI needs to be carefully
controlled for purity, protecting the D-value,
protecting the count, and so forth
Determine worst case inoculation site on the
item to be inoculated based on slowest to heat
location.
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 197
197
Performance Qualification:
Endotoxin Indicator Testing (1)
• Widely accepted method that demonstrates overkill or a
three log reduction of endotoxin
– Inoculation of endotoxin onto materials to be depyrogenated
– Recovery of endotoxin spike from treated components
198
99
9/18/2019
Performance Qualification:
Endotoxin Indicator Testing (2)
• Use actual items or representative coupon of
surface type to be depyrogenated
– Heat resistance and effectiveness of the
depyrogenation process may be influenced by
carrier type
• Adsorption of endotoxin spike to carrier surface is
biggest obstacle affecting recovery
• Use commercially available EIs or endotoxin
challenge vials in place of actual production items
or representative coupons
– Must demonstrate equivalent or worst-case
challenge to the depyrogenation process
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 199
199
Performance Qualification:
Endotoxin Indicator Testing (3)
200
100
9/18/2019
Performance Qualification:
Process Equivalency (1)
201
Performance Qualification:
Process Equivalency (2)
Conveyor speed
Materials of construction
202
101
9/18/2019
Performance Qualification:
Process Equivalency (3)
• Regulatory approval may
be required to support a
reduction in qualification
testing
203
Performance Qualification:
Operational Equivalence
• Established by an analysis of all process data
associated with validated process in new
equipment
• Compare chamber and load profiles using the same
critical process parameters
• Confirm the specifications, acceptance criteria, and
load configuration are the same as those used in
established sterilization validation process of
existing equipment
204
102
9/18/2019
Performance Qualification
Heat
Load Temperature
penetration, FH
configurations distribution
value range
Heat-up and
BI or EI cool down times
inactivation of the
product/item
205
206
103
9/18/2019
207
208
104
9/18/2019
Section 8:
Ongoing Process
Control
209
After
After release of
On a continual completion of
the equipment
basis performance
for use
qualification
210
105
9/18/2019
211
212
106
9/18/2019
Oven: Tunnel:
• Time at temperature • Temperature
(such as minimum heat up
time, minimum exposure or • Conveyor belt
dwell time and minimum cool- speed
down)
• Temperature set- • Differential
point exposure pressure
(between tunnel and clean
• Differential pressure room/cold zone/ tunnel room)
as applicable (e.g.,
between double door batch
oven and a room)
213
• Establish program to
assure that ovens and
tunnels remain
mechanically sound and
capable of continuously
meeting process
requirements
• Consider vendor
recommendations
214
107
9/18/2019
215
216
108
9/18/2019
217
218
109
9/18/2019
219
220
110
9/18/2019
221
222
111
9/18/2019
Change Written
Training
control procedures
Planned Failure
Prevention of
preventative mode/risk
human error
maintenance analysis
Product
Validation Calibration release
requirements
223
224
112
9/18/2019
225
226
113
9/18/2019
227
228
114
9/18/2019
229
230
115
9/18/2019
231
Conclusions (1)
• Dry heat processes can provide sterilization or both
depyrogenation and sterilization
– The purpose of the process will dictate the validation
approach
• The dry heat equipment and its support systems
should be designed and constructed to deliver
effective processes in a consistent and reproducible
manner
• The goal of process development is to identify critical
and key operating parameters that will result in a load
meeting the minimum acceptance criteria for
depyrogenation / sterilization
Validation of Dry Heat Processes
© 2013 Parenteral Drug Association 232
232
116
9/18/2019
Conclusions (2)
233
Questions
234
117
9/18/2019
Thank You
235
118